Research Topics
Genomes and Genes | Haojie LiSummaryAffiliation: Harvard Medical School Country: USA Publications
| Collaborators
|
Detail Information
Publications
A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancerHaojie Li
Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America
PLoS Med 4:e103. 2007..Few studies have explored the joint association of circulating vitamin D levels with VDR polymorphisms...- Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysisJing Ma
Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
Lancet Oncol 9:1039-47. 2008..We assessed the effect of prediagnostic BMI and plasma C-peptide concentration (reflecting insulin secretion) on prostate cancer-specific mortality after diagnosis... 
Prostate cancer risk and ESR1 TA, ESR2 CA repeat polymorphismsMatthew H McIntyre
Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA
Cancer Epidemiol Biomarkers Prev 16:2233-6. 2007..Experimental evidence has suggested that estrogen receptor alpha (coded by the gene ESR1) might increase prostate cancer risk, whereas estrogen receptor beta (coded by the gene ESR2) might reduce prostate cancer risk...- Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancerHaojie Li
Channing Laboratory, Department of Medicine Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
Cancer Res 65:2498-504. 2005..Both endogenous and exogenous antioxidants play an important and interdependent role in preventing clinically significant prostate cancer... - Polymorphism in endostatin, an angiogenesis inhibitor, and prostate cancer risk and survival: A prospective studyLorelei A Mucci
Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
Int J Cancer 125:1143-6. 2009..However, our data indicate that prostate cancer cases who carry the variant N allele are more likely to be overweight, and may be more susceptible to the angiogenic influences of obesity in prostate cancer pathogenesis... - Prostate-specific membrane antigen expression as a predictor of prostate cancer progressionSven Perner
Pathology, Brigham and Women s Hospital, Boston, MA 02115, USA
Hum Pathol 38:696-701. 2007..6-9.7, P < .001, respectively). In summary, PSMA is independently associated with PSA recurrence in a high-risk cohort and thus might provide insight into the additional use of adjuvant therapy. Validation on other cohorts is required... - Plasma levels of acid-labile subunit, free insulin-like growth factor-I, and prostate cancer risk: a prospective studyLorelei A Mucci
Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
Cancer Epidemiol Biomarkers Prev 19:484-91. 2010..Given the role of the IGF system in prostate cancer, ALS may influence carcinogenesis by modulating IGF-I levels or bioavailability... - Prediagnostic plasma vascular endothelial growth factor levels and risk of prostate cancerHaojie Li
Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Room 452, 181 Longwood Avenue, Boston, Massachusetts 02115, USA
Cancer Epidemiol Biomarkers Prev 14:1557-61. 2005..Our results indicate that prediagnostic circulating VEGF levels are not associated with prostate cancer development and have limited value in predicting future risk of prostate cancer... - Hypoxia-inducible factor-1alpha (HIF-1alpha) gene polymorphisms, circulating insulin-like growth factor binding protein (IGFBP)-3 levels and prostate cancerHaojie Li
Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
Prostate 67:1354-61. 2007.... - A prospective study of plasma selenium levels and prostate cancer riskHaojie Li
Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
J Natl Cancer Inst 96:696-703. 2004..We examined the association between pre-diagnostic plasma selenium levels and risk of prostate cancer in men enrolled in the Physicians' Health Study... - Prospective study of plasma vitamin B6 and risk of colorectal cancer in menJung Eun Lee
Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
Cancer Epidemiol Biomarkers Prev 18:1197-202. 2009..92 (0.55-1.56), 0.42 (0.23-0.75), and 0.49 (0.26-0.92; P(trend) = 0.01), respectively. In conclusion, vitamin B(6) may protect against colorectal cancer independent of other one-carbon metabolites and inflammatory biomarkers... - The role of metastasis-associated protein 1 in prostate cancer progressionMatthias D Hofer
Department of Pathology, Brigham and Women s Hospital, Boston, Massachusetts, USA
Cancer Res 64:825-9. 2004..In summary, this study identified an association of MTA1 expression and prostate cancer progression... - Prognostic factors in lymph node-positive prostate cancerMatthias D Hofer
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA
Urology 67:1016-21. 2006..These parameters may be useful in predicting PSA recurrence in lymph node-positive PCa and could be included in patient follow-up... - A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer riskJorge E Chavarro
Department of Nutrition, Harvard School of Public Health, 665 Huntington Avenue, Boston, MA 02115, USA
Cancer Epidemiol Biomarkers Prev 16:1364-70. 2007..Animal models suggest that n-3 fatty acids inhibit prostate cancer proliferation, whereas n-6 fatty acids promote it, but epidemiologic studies do not uniformly support these findings...